# ULTRASION S.L.
EUACC page: https://www.euacc.ai/company/ultrasion-s-l-966426424
Retrieved: 2026-10-18T01:48:45.855Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**id:** 6234881e-8309-4e54-8183-7832e285478d
**slug:** ultrasion-s-l-966426424
**name:** ULTRASION S.L.
**tagline:** Optogenetic Protein Therapy for Multiple Sclerosis
**description:** ULTRASION S.L. is a private SME recorded in CORDIS in Spain, with participation in 5 EU research and innovation projects. Its recorded projects include “Optogenetic Protein Therapy for Multiple Sclerosis”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**country:** Spain
**country code:** ES
**city:** CERDANYOLA DEL VALLES
**sector tags:** 
  - Deep Tech
**stage:** grant-funded
**website:** http://www.ultrasion.com/
**grants received:** €1,022,030
**open to funding:** false
**source:** cordis
**cordis programme:** Horizon 2020
**cordis org id:** 966426424
**cordis url:** https://cordis.europa.eu/project/id/720694
**grant id:** 720694
**eu contribution:** 1022030
**created at:** 2026-10-14T19:21:04.317529+00:00
**updated at:** 2026-10-14T19:16:32.373+00:00
**mrr status:** private
**value proposition:** ULTRASION S.L. is a private SME recorded in CORDIS in Spain, with participation in 5 EU research and innovation projects. Its recorded projects include “Optogenetic Protein Therapy for Multiple Sclerosis”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**status:** published

## Review record

**status:** missing
**source url:** http://www.ultrasion.com/
**next check due:** 2026-10-14T19:28:38.926+00:00

## Source metadata